Related references
Note: Only part of the references are listed.Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis
N. Wahlgren et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Plasmin: A Modulator of Immune Function
Dominik Draxler et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease
Maureen A. Shaw et al.
JOURNAL OF NEUROSCIENCE (2017)
Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model
Lawrence N. Diebel et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2017)
Selective inhibition of brain endothelial Rhokinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin
Be'eri Niego et al.
PLOS ONE (2017)
Fibrinolysis in Trauma: Myth, Reality, or Something in Between
Mark Walsh et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
TRANEXAMIC ACID ATTENUATES THE LOSS OF LUNG BARRIER FUNCTION IN A RAT MODEL OF POLYTRAUMA AND HEMORRHAGE WITH RESUSCITATION
Xiaowu Wu et al.
SHOCK (2017)
Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model
Lawrence N. Diebel et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2017)
Tissue plasminogen activator mediates deleterious complement cascade activation in stroke
Xue-Jun Zhao et al.
PLOS ONE (2017)
Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke
Fabricio Simao et al.
BLOOD (2017)
Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin- and bradykinin-dependent mechanism
Oscar A. Marcos-Contreras et al.
BLOOD (2016)
Preventive Ceftriaxone in Patients with Stroke Treated with Intravenous Thrombolysis: Post Hoc Analysis of the Preventive Antibiotics in Stroke Study
Jan-Dirk Vermeij et al.
CEREBROVASCULAR DISEASES (2016)
tPA promotes cortical neuron survival via mTOR-dependent mechanisms
Julia A. Grummisch et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2016)
Translocation and dissemination of commensal bacteria in post-stroke infection
Dragana Stanley et al.
NATURE MEDICINE (2016)
Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke
Renee J. Turner et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice
Nuha Hijazi et al.
BLOOD (2015)
The gut reaction to traumatic brain injury
Rebeccah J. Katzenberger et al.
FLY (2015)
The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial
Willeke F. Westendorp et al.
LANCET (2015)
The Fibrinolytic System-More Than Fibrinolysis?
Dominik F. Draxler et al.
TRANSFUSION MEDICINE REVIEWS (2015)
Tissue plasminogen activator inhibits NMDA-receptor-mediated increases in calcium levels in cultured hippocampal neurons
Samuel D. Robinson et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface
Sophia Bardehle et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Tissue-type plasminogen activator is a neuroprotectant in the central nervous system
Manuel Yepes
Frontiers in Cellular Neuroscience (2015)
Imatinib treatment reduces brain injury in a murine model of traumatic brain injury
Enming J. Su et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Dendritic Cell-Mediated Phagocytosis but Not Immune Activation Is Enhanced by Plasmin
Rachael J. Borg et al.
PLOS ONE (2015)
Plasminogen promotes macrophage phagocytosis in mice
Riku Das et al.
BLOOD (2014)
Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage A Meta-analysis
Saurav Chatterjee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Plasmin-dependent modulation of the blood brain barrier: a major consideration during tPA-induced thrombolysis?
Be'eri Niego et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Plasmin deficiency leads to fibrin accumulation and a compromised inflammatory response in the mouse brain
K. Hultman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Exogenous t-PA Administration Increases Hippocampal! Mature BDNF Levels. Plasmin- or NMDA-Dependent: Mechanism?
Marion Rodier et al.
PLOS ONE (2014)
A comparative study of the immune modulating properties of antifibrinolytics in cardiac surgery
A. F. L. Later et al.
CYTOKINE (2013)
Tissue-type plasminogen activator is an extracellular mediator of Purkinje cell damage and altered gait
Elisa J. Cops et al.
EXPERIMENTAL NEUROLOGY (2013)
Antifibrinolytics attenuate inflammatory gene expression after cardiac surgery
Alexander F. L. Later et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)
Immunotherapy blocking the tissue plasminogen activator-dependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome
Thomas Gaberel et al.
NEUROPHARMACOLOGY (2013)
Tissue plasminogen activator regulates Purkinje neuron development and survival
Jianxue Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes
Be'eri Niego et al.
BLOOD (2012)
The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans
Maithili Sashindranath et al.
BRAIN (2012)
Plasminogen Is a Complement Inhibitor
Diana Barthel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-alpha
Woldeab B. Haile et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Plasmin as a proinflammatory cell activator
Tatiana Syrovets et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Tissue-Type Plasminogen Activator Regulates the Neuronal Uptake of Glucose in the Ischemic Brain
Fang Wu et al.
JOURNAL OF NEUROSCIENCE (2012)
Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator
M. M. C. G. Silva et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
A RHO KINASE (ROCK) INHIBITOR, FASUDIL, PREVENTS MATRIX METALLOPROTEINASE-9-RELATED HEMORRHAGIC TRANSFORMATION IN MICE TREATED WITH TISSUE PLASMINOGEN ACTIVATOR
M. Ishiguro et al.
NEUROSCIENCE (2012)
Nucleocytoplasmic Coagulation: An Injury-Induced Aggregation Event that Disulfide Crosslinks Proteins and Facilitates Their Removal by Plasmin
Andre L. Samson et al.
CELL REPORTS (2012)
Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruption
Yao Yao et al.
JOURNAL OF CELL SCIENCE (2011)
Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation
Maithili Sashindranath et al.
LABORATORY INVESTIGATION (2011)
Tissue plasminogen activator is required for the development of fetal alcohol syndrome in mice
Melissa Noel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Antibodies Preventing the Interaction of Tissue-Type Plasminogen Activator With N-Methyl-D-Aspartate Receptors Reduce Stroke Damages and Extend the Therapeutic Window of Thrombolysis
Richard Macrez et al.
STROKE (2011)
FIBRINOLYTIC ACTIVITY OF HUMAN BRAIN. A HISTOCHEMICAL STUDY
Davut Tovi
ACTA NEUROLOGICA SCANDINAVICA (2010)
Temporally and Regionally Disparate Differences in Plasmin Activity by Tranexamic Acid
Daryl L. Reust et al.
ANESTHESIA AND ANALGESIA (2010)
NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity
A. Baron et al.
CELL DEATH AND DIFFERENTIATION (2010)
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
Haleema Shakur et al.
LANCET (2010)
Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury
Dan Shlosberg et al.
NATURE REVIEWS NEUROLOGY (2010)
Functional Occurrence of the Interaction of Tissue Plasminogen Activator With the NR1 Subunit of N-Methyl-D-Aspartate Receptors During Stroke
Richard Macrez et al.
STROKE (2010)
A nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury
Andre L. Samson et al.
BLOOD (2009)
Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein
Yasuhiro Suzuki et al.
BLOOD (2009)
Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke
Enming J. Su et al.
NATURE MEDICINE (2008)
Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice
P. K. Witting et al.
THROMBOSIS RESEARCH (2008)
Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative Vitreoretinopathy
Hetian Lei et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice
Y. Suzuki et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Anti-NR1N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory
Karim Benchenane et al.
JOURNAL OF CELL SCIENCE (2007)
Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial
Juan J. Jimenez et al.
CRITICAL CARE (2007)
Neutralizing the neurotoxic effects of exogenous and endogenous tPA
William M. Armstead et al.
NATURE NEUROSCIENCE (2006)
Neural stem cells rescue nervous Purkinje neurons by restoring molecular homeostasis of tissue plasminogen activator and downstream targets
Jianxue Li et al.
JOURNAL OF NEUROSCIENCE (2006)
New transgenic evidence for a system of sympathetic axons able to express tissue plasminogen activator (t-PA) within arterial/arteriolar walls
Zhifang Hao et al.
BLOOD (2006)
Effects of fasudil in acute ischemic stroke: Results of a prospective placebo-controlled double-blind trial
M Shibuya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Central nervous system injury-induced immune deficiency syndrome
C Meisel et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Regulation of brain proteolytic activity is necessary for the in vivo function of NMDA receptors
M Kvajo et al.
JOURNAL OF NEUROSCIENCE (2004)
Tissue plasminogen activator and NMDA receptor cleavage
T Matys et al.
NATURE MEDICINE (2003)
Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein
M Yepes et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke
ZG Zhang et al.
CIRCULATION (2002)
Tissue plasminogen activator is required for corticostriatal long-term potentiation
D Centonze et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Reduced cortical injury and edema in tissue plasminogen activator knockout mice after brain trauma
T Mori et al.
NEUROREPORT (2001)
Control elements between-9.5 and-3.0 kb in the human tissue-type plasminogen activator gene promoter direct spatial and inducible expression to the murine brain
H Yu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Plasminogen expression in the neonatal and adult mouse brain
ME Basham et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling
O Nicole et al.
NATURE MEDICINE (2001)
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory
P Calabresi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
